OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 15 filers reported holding OPIANT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fondren Management LP | 186,900 | $1,688,000 | 6.52% |
| Mesirow Financial Investment Management, Inc. | 19,780 | $179,000 | 0.84% |
| Alambic Investment Management, L.P. | 15,312 | $138,000 | 0.35% |
| PERRITT CAPITAL MANAGEMENT INC | 29,500 | $266,000 | 0.20% |
| GSA CAPITAL PARTNERS LLP | 13,527 | $122,000 | 0.07% |
| American Research & Management Co. | 300 | $3,000 | 0.00% |
| Renaissance Technologies | 187,970 | $1,697,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 1,467 | $13,000 | 0.00% |
| Lindbrook Capital, LLC | 500 | $5,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 32,521 | $293,000 | 0.00% |